av/puma-biotechnology--big.svg

COM:PUMABIOTECHNOLOGY

Puma Biotechnology, Inc.

  • Stock

USD

Last Close

2.91

14/02 21:00

Market Cap

146.65M

Beta: -

Volume Today

198.19K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
27.70M
-
251M
806.14%
272.30M
8.49%
225.10M
17.33%
253.20M
12.48%
228M
9.95%
235.64M
3.35%
cost of revenue
5.60M
-
34.60M
517.86%
36.80M
6.36%
39.40M
7.07%
63.70M
61.68%
55.10M
13.50%
62.68M
13.76%
gross profit
22.10M
-
216.40M
879.19%
235.50M
8.83%
185.70M
21.15%
189.50M
2.05%
172.90M
8.76%
172.96M
0.03%
selling and marketing expenses
12K
-
1.19M
9,825%
-88K
107.39%
6K
106.82%
22K
266.67%
881K
3,904.55%
general and administrative expenses
19.40M
-
31.80M
63.92%
53.80M
69.18%
106.70M
98.33%
146.19M
37.01%
140.51M
3.88%
118.49M
15.67%
116.29M
1.85%
89.98M
22.63%
88.43M
1.72%
selling general and administrative expenses
19.40M
-
31.80M
63.92%
53.80M
69.18%
106.70M
98.33%
146.20M
37.02%
141.70M
3.08%
118.40M
16.44%
116.30M
1.77%
90M
22.61%
89.31M
0.77%
research and development expenses
122.90M
-
208.50M
69.65%
222.80M
6.86%
207.80M
6.73%
164.90M
20.64%
132.90M
19.41%
97.70M
26.49%
71.90M
26.41%
52.20M
27.40%
50.38M
3.48%
other expenses
-14K
-
25K
278.57%
-400K
1,700%
-100K
75%
-9.70M
9,600%
200K
102.06%
400K
100%
300K
25%
-28K
109.33%
759K
2,810.71%
cost and expenses
142.30M
-
240.30M
68.87%
276.60M
15.11%
320.10M
15.73%
345.70M
8.00%
311.40M
9.92%
255.50M
17.95%
251.90M
1.41%
197.30M
21.68%
202.37M
2.57%
operating expenses
142.30M
-
240.30M
68.87%
276.60M
15.11%
314.50M
13.70%
311.10M
1.08%
274.60M
11.73%
216.10M
21.30%
188.20M
12.91%
142.20M
24.44%
139.69M
1.77%
interest expense
324K
-
971K
199.69%
958K
1.34%
700K
26.93%
11M
1,471.43%
15M
36.36%
14.10M
6%
12.80M
9.22%
11.50M
10.16%
13.33M
15.91%
ebitda
-142.30M
-
-240.30M
68.87%
-276.60M
15.11%
-291.30M
5.31%
-102.60M
64.78%
-36.10M
64.81%
-29.50M
18.28%
1.70M
105.76%
31.50M
1,752.94%
44.78M
42.17%
operating income
-142.30M
-
-240.30M
68.87%
-276.60M
15.11%
-292.40M
5.71%
-94.70M
67.61%
-39.10M
58.71%
-30.40M
22.25%
-8.90M
70.73%
23.70M
366.35%
33.27M
40.36%
depreciation and amortization
627K
-
776K
23.76%
1.15M
48.07%
2.81M
144.65%
7.38M
162.68%
3M
59.37%
900K
70%
10.60M
1,077.56%
7.80M
26.40%
11.52M
47.68%
total other income expenses net
-14K
-
25K
278.57%
-400K
1,700%
-100K
75%
-9.70M
9,600%
-36.50M
276.29%
-29.40M
19.45%
-19.90M
32.31%
-23.20M
16.57%
-10.59M
54.35%
income before tax
-142M
-
-239.30M
68.52%
-276M
15.34%
-292M
5.80%
-113.60M
61.10%
-75.60M
33.45%
-59.80M
20.90%
-28.80M
51.84%
500K
101.74%
22.67M
4,434.80%
income tax expense
-941K
-
-1.75M
86.08%
-2.15M
22.73%
-2.21M
2.89%
-7.92M
258.12%
7.12M
189.96%
200K
97.19%
300K
50%
500K
66.67%
1.08M
116.60%
net income
-142M
-
-239.30M
68.52%
-276M
15.34%
-292M
5.80%
-113.60M
61.10%
-82.72M
27.18%
-60M
27.47%
-29.10M
51.50%
912K
103.13%
21.59M
2,267.43%
weighted average shs out
30.01M
-
32.13M
7.05%
33.30M
3.64%
37.17M
11.64%
37.94M
2.08%
38.77M
2.18%
39.58M
2.08%
40.64M
2.69%
44.67M
9.93%
47.13M
5.51%
weighted average shs out dil
30.01M
-
32.13M
7.05%
33.30M
3.64%
37.17M
11.64%
37.94M
2.08%
38.77M
2.18%
39.58M
2.08%
40.64M
2.69%
44.93M
10.56%
47.55M
5.83%
eps
-4.73
-
-7.45
57.51%
-8.29
11.28%
-7.86
5.19%
-2.99
61.96%
-2.13
28.76%
-1.52
28.64%
-0.72
52.63%
0.02
102.83%
0.46
2,154.90%
epsdiluted
-4.73
-
-7.45
57.51%
-8.29
11.28%
-7.86
5.19%
-2.99
61.96%
-2.13
28.76%
-1.52
28.64%
-0.72
52.63%
0.02
102.82%
0.45
2,116.75%

All numbers in USD (except ratios and percentages)